Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-20-010847

Options or other derivatives

  • See Remarks acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
DAVIS JOHN C. JR See Remarks 2020-04-14 Grant or award · Stock Option (Right to Buy) +50,000 50,000 D
Loading xslF345X03/doc4.xml…